Where does MR-guided focused ultrasound technology stand now?
MR-guided focused ultrasound technology has just begun to have an impact. Currently, MR-guided focused ultrasound surgery has been approved by the U.S. Food and Drug Administration (FDA) for treatment of uterine fibroids and has obtained CE-mark approval in Europe for uterine fibroids and pain from bone metastases. There are ongoing clinical trials in the United States for bone metastases, uterine fibroids, breast tumors, and brain tumors. In the near future, clinical trials will begin for prostate and liver tumors, while studies for stroke, epilepsy, movement disorders, pancreatic, and kidney disorders are in the planning stage.
